Flora Growth Corp. Appoints Omar Sharif Jr. as Special Advisor, Strengthening Commitment to Diversity and Social Advocacy
Fort Lauderdale, Florida--(Newsfile Corp. - October 16, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") proudly announces the appointment of Omar Sharif Jr., internationally acclaimed activist, author, actor, and model, as a Special Advisor. This reflects Flora's ongoing dedication to advocating for diversity, inclusion, and progressive social change within the global cannabis community.
Omar Sharif Jr. is recognized for his public advocacy for LGBTQ+ rights, human rights, and social justice. As an outspoken advocate, Sharif has used his platform to address issues affecting marginalized communities worldwide. His influence extends across borders, particularly in his efforts to advance visibility and protection for LGBTQ+ individuals in regions where such rights remain deeply challenged, and for people living with HIV/AIDS globally.
"We welcome Omar Sharif Jr. to the Flora Growth family as a Special Advisor," said Clifford Starke, Chairman and Chief Executive Officer. "Omar's tireless advocacy for equality and human rights aligns with Flora's core values of inclusivity and responsible business practices. We believe that promoting diversity and supporting social causes is not just a moral imperative but a business responsibility. With Omar's guidance, we aim to broaden our social impact, championing inclusion in everything we do."
Omar Sharif Jr. brings a wealth of experience from his extensive work in activism and entertainment. The grandson of legendary actor Omar Sharif, he has worked with various organizations, including GLAAD, The Elizabeth Taylor AIDS Foundation, Human Rights Foundation, and the United Nations to bring attention to issues like discrimination, inequality, and the plight of refugees. His voice has been pivotal in shaping narratives around acceptance and understanding in global forums, and he has contributed to legislative discussions surrounding LGBTQ+ rights in multiple countries.
"I am honored to join Flora Growth Corp. as a Special Advisor," said Sharif. "Throughout my career, I've sought to bring visibility to important social issues and fight for marginalized communities. Cannabis has increasingly been a powerful tool in promoting wellness, and mental well-being. I believe Flora's approach to responsible cannabis growth, distribution, and advocacy can significantly contribute to societal change. Together, we will work toward ensuring that the benefits of this industry are accessible to all, especially those who have historically been excluded or disproportionately affected by punitive policies."
Sharif's role as Special Advisor will focus on guiding Flora Growth's initiatives aimed at advancing inclusion, social equity, and diversity within both the company and the cannabis industry at large. He will work closely with Flora's leadership team to develop strategies that foster greater representation, particularly for LGBTQ+ individuals and other underrepresented communities in the cannabis sector.
"As we grow, Flora Growth aspires to uplift voices like Omar's that have the power to bring about real change," added Starke. "His passion for advocacy and his willingness to challenge the status quo will be instrumental as we continue to make strides toward a more inclusive and equitable future in cannabis and beyond."
About Flora Growth Corp.
Flora Growth Corp.'s mission is to become the leading NASDAQ small-cap international cannabis company. Flora is a cannabis-focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit www.floragrowth.com.
https://www.phatebo.de/home-en
https://www.australianvaporizers.com.au/
Investor Relations:
Investor Relations ir@floragrowth.com
Clifford Starke Clifford.Starke@floragrowth.com
Media:
Cautionary Statement Concerning Forward-Looking Statements
This press release contains "forward-looking statements," as defined by U.S. federal securities laws. Forward-looking statements reflect Flora's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar expressions generally identify forward-looking statements. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled "Risk Factors" in Flora's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the "SEC") on March 28, 2024, as such factors may be updated from time to time in Flora's periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov/edgar. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora's filings with the SEC. While forward-looking statements reflect Flora's good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/226735
